The Global Drug Trade

Chapter Opening

In the early hours of a January morning in 2017, Mexican authorities watched as a series of modified vehicles carrying welding equipment entered the grounds of the Altiplano Federal Prison, the most secure detention facility in Mexico. Within minutes, a tunnel exit opened in a storage room, and Joaquín Archivaldo Guzmán Loera, known to the world as El Chapo, disappeared underground. It was the second time he had escaped from that prison, and the escape had required months of excavation, sophisticated ventilation systems, a motorcycle mounted on tracks, and the coordination of dozens of people both inside and outside the prison walls. The event was a global sensation, a kind of dark theater that illustrated something important: the drug trade, at its height, could outmaneuver the resources of a nation-state.

That spectacle, however, was only the latest episode in a story that stretches back much further than the cartel era of the late twentieth century. Human beings have used psychoactive substances, including plants and fungi with mood-altering properties, since prehistoric times. What changed in the nineteenth and twentieth centuries was not the human appetite for intoxication but something far more consequential: the industrialization of production, the globalization of trade, the intervention of governments in classifying and prohibiting certain substances, and the emergence of organized criminal enterprises sophisticated enough to supply global markets despite legal prohibition. The result was the modern drug trade, one of the largest illegal industries in human history and one of the most consequential forces shaping organized crime, international relations, public health, and the governance of states across the globe.

This chapter traces the origins and development of the modern narcotics trade from its roots in the nineteenth-century opium economy through the emergence of cocaine, heroin, and methamphetamine as the dominant commodities of the late twentieth and early twenty-first centuries. It examines not only the criminal organizations that profit from the trade but the economic logic that makes illicit drug markets so durable, the supply chains that move narcotics across continents and oceans, and the societies of producers and consumers whose lives are shaped by the industry in profoundly different ways. It asks why prohibition, for all its stated purposes, has consistently generated the conditions that allow organized crime to thrive, and why the global drug trade has proved so resistant to even the most determined law enforcement efforts.

Understanding the drug trade requires understanding it as a global economic system, not simply a catalogue of criminal organizations. Farmers in the Andes, the Golden Triangle, and the Golden Crescent cultivate coca, opium poppies, and cannabis under conditions of poverty, limited alternatives, and sometimes violent coercion. Intermediaries move raw materials through multiple stages of processing. Transportation networks, often run by criminal organizations with the sophistication of international logistics companies, move product across borders using methods that range from submarines to drones to diplomatic pouches. Distributors at multiple levels control retail markets in destination countries. Financial systems, both legitimate and illicit, launder and invest the proceeds. And at the end of the chain, in cities and suburbs and rural communities across the wealthiest nations, consumers purchase a product that governments have classified as illegal at enormous personal, social, and public health cost.

The people involved in this system occupy very different positions of power and vulnerability. The farmer in Guerrero or Helmand Province who grows poppy because it is the only reliable cash crop in his region is not equivalent to the cartel boss who directs the processing and transportation of heroin across international borders. The teenager in Baltimore or Glasgow who buys a small quantity of drugs from a street dealer is not equivalent to the financial professional who launders hundreds of millions of dollars in drug proceeds through shell companies and offshore accounts. The drug trade involves extreme inequality, extreme violence, and the systematic exploitation of the poorest and most vulnerable people at the bottom of global supply chains. Understanding this complexity is essential to understanding both the history and the policy challenges that narcotics trafficking presents.

The chapter also examines the deep entanglement between the drug trade and political power. Prohibition, which made drug trafficking illegal and enormously profitable, created irresistible incentives for corruption. Police officers, prosecutors, judges, politicians, military officers, and border officials in countries around the world have been corrupted by drug money, compromising the institutions that are supposed to contain criminal enterprise. In the most extreme cases, entire political systems have been partially captured by narcotics interests, creating what scholars call narco-states or narco-democracies. These are not aberrations at the margins of the global system. They represent one of the most serious governance challenges of the modern era.

By the end of this chapter, students will understand why the modern drug trade exists, how it functions as an economic system, which criminal organizations have dominated it and how their dominance has shifted over time, what the social and political consequences of both drug prohibition and drug use have been, and why, despite decades of law enforcement effort and enormous expenditure, the global drug economy continues to grow. These are not simply historical questions. They are among the most urgent policy questions facing governments and societies around the world today.

Learning Objectives

Guiding Historical Questions

Historical Context

To understand the modern global drug trade, it is necessary to begin not with the cartel wars of the late twentieth century but with the much earlier history of how human societies have cultivated, used, regulated, and prohibited psychoactive substances. That history reveals that the contemporary crisis is not a sudden eruption of criminal behavior but the product of long economic, political, and cultural processes, many of them rooted in colonialism, industrialization, and the construction of the modern state.

Psychoactive plants have been used by human communities for thousands of years. Opium, derived from the juice of the opium poppy, was known to ancient Sumerians as a "joy plant" and was used medicinally and recreationally across the ancient Mediterranean and Middle East. Cannabis was cultivated across Asia for both fiber and intoxicating properties. Coca leaves were chewed by Andean communities in South America for their stimulant and altitude-sickness-relieving properties for at least two thousand years before European contact. These substances were embedded in cultural, religious, and medical practices and governed by social norms that constrained, though did not eliminate, their potential for harm.

What changed in the nineteenth century was the intersection of industrial chemistry, global trade, colonial economies, and eventually legal prohibition. The synthesis of morphine from opium in 1804, the discovery of heroin in 1898, the isolation of cocaine from coca leaves in 1855, and the later synthesis of various amphetamines in the 1930s transformed naturally occurring substances into far more potent and potentially addictive concentrated forms. These refined products moved through global trade networks that were already highly developed, and they were initially sold through entirely legal channels, including by major pharmaceutical companies. The British Empire built much of its China trade on opium, the consequences of which shaped Asian politics and society for more than a century. German pharmaceutical companies marketed heroin as a cough remedy and safer alternative to morphine. Coca-Cola's original formula included coca extract. Amphetamines were distributed to soldiers in multiple armies during the Second World War.

The construction of the modern international drug prohibition regime began in earnest in the early twentieth century, driven by a combination of genuine public health concerns, racial anxieties, and imperial politics. The International Opium Convention of 1912 was the first major international treaty restricting drug commerce. The Harrison Narcotics Tax Act of 1914 in the United States began the process of criminalizing non-medical opiate use. Successive international conventions expanded the list of controlled substances and the obligations of signatory states throughout the mid-twentieth century. By the time the United Nations Single Convention on Narcotic Drugs was adopted in 1961, a comprehensive international legal framework existed that classified a wide range of psychoactive substances as illegal for non-medical purposes and committed signatory states to criminalization and enforcement.

The critical economic consequence of this prohibition regime was to transform the production and sale of certain psychoactive substances into an extraordinarily lucrative criminal enterprise. When legal supply is eliminated, demand does not disappear. It goes underground, and the illegal supplier can charge prices far above the cost of production because the price includes a premium for the risk of arrest, prosecution, and punishment. This "prohibition premium" generates the enormous profits that make drug trafficking attractive to criminal organizations and that provide those organizations with the resources to corrupt institutions, acquire weapons, and compete violently for market share. Understanding this economic logic, which the rest of this chapter explores in detail, is the single most important intellectual tool for understanding why the drug trade takes the form it does.

Students should also understand the global geography of the drug trade. Production tends to be concentrated in regions characterized by poverty, weak state institutions, rugged terrain, and limited legal economic alternatives. Opium cultivation is concentrated in Afghanistan and, to a lesser degree, in the Golden Triangle region of Southeast Asia. Coca cultivation is concentrated in Colombia, Peru, and Bolivia. Cannabis is produced in many parts of the world but with major production centers in Morocco, Afghanistan, and various parts of Latin America and South Asia. Methamphetamine and other synthetic drugs are produced in laboratories that can be located almost anywhere, giving synthetic drug production a very different geographic profile than plant-based narcotics.

Transportation and transit networks connect producing regions to consuming markets, primarily in wealthy countries in North America, Western Europe, and increasingly East Asia and Australia. The major consuming markets generate the revenues that flow back through the supply chain, with the largest share captured at the distribution level rather than at the production level. This geography of inequality, in which producing-country farmers and communities bear the greatest burden of violence and instability while consuming-country users and governments largely shape policy, is one of the defining features of the global drug trade as a political and economic system.

Chronology Preview

Major People, Groups, and Places

Core Vocabulary Preview

The following key terms appear throughout this chapter. Students should develop familiarity with each term before proceeding to the main sections.

The Origins of Modern Narcotics Trafficking

The modern global drug trade did not spring into existence with the rise of Pablo Escobar or the Mexican cartels. Its roots lie in the intersection of three historical forces that converged during the nineteenth century: colonial trade politics, industrial pharmaceutical chemistry, and the first serious attempts by governments to regulate or prohibit the use of psychoactive substances. Understanding those roots is essential to understanding why the contemporary drug economy operates as it does.

The most consequential early chapter of what would become the modern drug trade was the British opium trade with China. By the early nineteenth century, the British East India Company controlled opium production in Bengal and was exporting enormous quantities of processed opium to China. Chinese officials recognized the devastating social consequences of widespread opium addiction and repeatedly attempted to restrict or ban importation. The British government, prioritizing the trade balance and the profits of the East India Company, refused to accept those restrictions. When Chinese authorities seized and destroyed a large shipment of British-owned opium in Canton in 1839, Britain responded militarily. The First Opium War of 1839 to 1842 ended with the Treaty of Nanking, which forced China to cede Hong Kong to Britain, open treaty ports to foreign trade, and effectively legalize opium importation. A second conflict in the late 1850s reinforced these concessions. The message was unambiguous: a colonial great power would use military force to protect the right of its merchants to sell addictive drugs in foreign markets.

The opium trade illustrated with stark clarity the political economy of drug commerce. The profits were captured largely by merchants and by the colonial government in the form of tax revenue. The costs, in terms of addiction and social disruption, were borne by Chinese society. This asymmetry, in which the benefits of drug commerce flow toward the powerful and the costs fall upon the vulnerable, has characterized the global drug trade in various forms ever since.

Meanwhile, the nineteenth century witnessed an industrial transformation in the pharmacology of psychoactive substances. When Friedrich Sertürner isolated morphine from opium in 1804, and when Charles Romley Alder Wright synthesized heroin from morphine in 1874, and when Albert Niemann isolated cocaine from coca leaves in 1860, chemists were producing substances of far greater potency and addictive potential than the naturally occurring plants from which they derived. These products were legally manufactured and widely sold, initially through pharmacies and by traveling medicine salesmen, later by established pharmaceutical companies. Bayer, the German company famous for aspirin, marketed heroin as a non-addictive substitute for morphine and a cough suppressant for children. Sigmund Freud praised cocaine as a wonder drug. Advertisements for cocaine-containing products appeared in mainstream newspapers and magazines. The problem of addiction was recognized but significantly underestimated, and the commercial incentives of manufacturers and distributors worked against acknowledgment of the harm their products caused.

By the late nineteenth and early twentieth centuries, growing public concern about addiction, combined with moral reform movements and, in the United States, explicitly racial anxieties about drug use by Black Americans, Chinese immigrants, and Mexican laborers, drove the first systematic attempts at legal restriction. The 1906 Pure Food and Drug Act required accurate labeling of patent medicines containing narcotics. The 1914 Harrison Narcotics Tax Act began the process of restricting opiates and cocaine to medical use, effectively criminalizing non-medical consumption. Internationally, a series of conventions beginning with the 1912 Hague Opium Convention committed signatory states to restrict the non-medical manufacture, sale, and distribution of opium, morphine, cocaine, and their derivatives.

The legal framework of prohibition, once established, had an immediate and predictable economic consequence: it created lucrative black markets. The demand for narcotics did not disappear because they became illegal. It went underground, and the illegal supplier could charge prices many times the cost of legal production because buyers were paying not only for the substance but for the risk the seller assumed in providing it. This "prohibition premium" transformed the economics of drug commerce in the same way that the Volstead Act transformed the economics of alcohol commerce: it handed a hugely profitable market to whoever was willing and able to supply it outside the law. Organized criminals, already well practiced in operating outside legal constraints, were ideally positioned to fill that role.

The early decades of the twentieth century saw the consolidation of the international prohibition regime alongside the emergence of organized criminal markets. In the United States, the narcotics black market that developed in the 1920s was initially served by some of the same criminal networks that had developed during alcohol Prohibition, with Italian American organized crime figures, Jewish gangsters, and others adding narcotics to their portfolios of illegal commerce. Heroin and cocaine were sold through networks of illicit pharmacies, street dealers, and criminal distributors in American cities. Similar markets existed in Europe and in the colonial possessions of European empires, where the combination of legal restriction and persistent demand created ongoing criminal opportunity.

The international framework tightened further in the mid-twentieth century. The 1961 UN Single Convention on Narcotic Drugs consolidated earlier treaties and committed signatory states to prohibiting the production, sale, and possession of a comprehensive list of substances except for medical and scientific purposes. It was followed by the 1971 Convention on Psychotropic Substances and the 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. This legal architecture, covering virtually every country in the world, formed the basis of the international drug prohibition regime that governs the present day. By the late twentieth century, the combination of global prohibition and persistent global demand had created the conditions for some of the most powerful criminal organizations in history.

Opium: The First Global Drug

Of all the substances that define the modern drug trade, opium and its derivatives have the longest and most consequential history. The opium poppy, Papaver somniferum, produces a milky sap containing alkaloids including morphine and codeine. When dried and processed, this sap becomes raw opium, which can be further refined into morphine and then into heroin, the most potent and commercially valuable opioid derivative. The journey from poppy field to heroin consumer, spanning thousands of miles and multiple stages of processing and transportation, is one of the defining supply chains of global organized crime.

Through the late nineteenth and early twentieth centuries, opium production was geographically dispersed. Turkey was a major producer, as were Iran, India, and parts of Southeast Asia. The commercial opium trade moved through British, French, and Dutch colonial networks. After the establishment of international prohibition, production began to concentrate in areas where state control was weak or absent, where geography made enforcement difficult, and where farmers had few alternative sources of income.

The Golden Triangle

The Golden Triangle, the mountainous border region where Myanmar, Laos, and Thailand meet, became one of the world's primary opium-producing regions in the mid-twentieth century. The region's rugged terrain, its distance from effective government control, and the poverty of its highland communities made it ideal territory for poppy cultivation. The Nationalist Chinese armies that retreated into Burma after the Communist victory in 1949 became early participants in the opium trade, using drug revenues to fund their continued military operations. The CIA, during the Cold War, turned a blind eye to the drug activities of anti-Communist forces it supported in the region, a connection later documented by journalist Alfred McCoy and others. Khun Sa, a Shan warlord who controlled much of the Golden Triangle opium trade from the 1960s until his surrender to Burmese authorities in 1996, built what amounted to a private army funded by narcotics revenues.

The Golden Triangle's dominance declined significantly from the 1990s onward as Afghanistan rose to global supremacy in opium production. By the 2010s, Myanmar remained a significant producer, with production largely controlled by ethnic armed organizations in the Shan State and other border regions. Laos remained a minor producer. Thailand had successfully reduced domestic cultivation through a combination of enforcement and crop substitution programs, though it remained an important transit country.

The Golden Crescent and Afghan Supremacy

The most dramatic development in the global opium economy over the past half century has been the emergence of Afghanistan as by far the world's leading producer. In the 1970s, Afghanistan was a minor contributor to global supply. The Soviet invasion of 1979 and the subsequent decade of war transformed the country's opium economy entirely. The mujahideen resistance fighters financed their war partly through opium production, and the CIA and Pakistani intelligence services, supporting the anti-Soviet jihad, again largely ignored the narcotics dimension of their allies' activities. By the time Soviet forces withdrew in 1989, Afghanistan's opium production had expanded enormously.

The Taliban government that took power in the mid-1990s initially attempted to suppress opium cultivation for religious reasons, issuing a ban in 2000 that briefly reduced production dramatically. But the fall of the Taliban after the US-led invasion of 2001 created conditions of state collapse that were extraordinarily favorable to poppy cultivation. The new Afghan government, dependent on warlords and power brokers who were deeply involved in the narcotics trade, could not or would not suppress cultivation. By the mid-2000s, Afghanistan was producing between 80 and 90 percent of the world's illicit opium. The Taliban, seeking to rebuild their capacity, returned to taxing poppy cultivation and the movement of opium and heroin as a primary revenue source. Drug money funded the insurgency that the United States and its allies were spending hundreds of billions of dollars to suppress.

The Afghan opium economy illustrates with particular clarity the relationship between state failure, poverty, and drug production. The poppy was not a traditional crop in Afghanistan but became dominant because the combination of war, poverty, and the destruction of agricultural infrastructure left farmers with few alternatives. A kilogram of dry opium could earn a farmer many times what other crops could generate on the same land. The processing and transportation margins were captured by intermediaries and trafficking organizations, leaving farmers with a modest but vital share of the total value. Eradication programs that destroyed crops without providing alternative livelihoods simply impoverished the farmers without reducing production, since other farmers moved into the space created. The fundamental economics of the opium economy could not be changed by enforcement alone.

From Opium to Heroin: The Processing Chain

Raw opium is only the beginning of the production chain. Processing into morphine and then heroin dramatically increases the value-to-weight ratio, making the product far more economical to transport over long distances. A kilogram of raw opium requires roughly ten kilograms of poppy sap to produce, and processing into heroin further reduces bulk while increasing potency and street value enormously. Processing laboratories, historically located close to production zones, have migrated over time in response to enforcement pressure and the availability of precursor chemicals.

Heroin from Afghanistan moves through several major trafficking corridors. The Balkan route runs through Iran and Turkey and into Western Europe, the largest consuming market for Afghan heroin. The northern route moves through Central Asian states into Russia and Eastern Europe. A southern route moves through Pakistan and on by sea toward East Africa, Southeast Asia, and Oceania. Each of these corridors is controlled by different trafficking organizations, with significant involvement of Iranian, Turkish, Pakistani, and Russian criminal networks at different stages.

In consumer markets, heroin passes through additional distribution layers before reaching street level. In Western European cities, it may move through Albanian, Turkish, or North African distribution networks. In the United States, heroin was for decades more of a regional product, with Mexican black tar heroin dominating western markets and white powder heroin from South America or Southwest Asia dominating eastern cities. The emergence of synthetic opioids, particularly fentanyl, has since transformed the American market in ways described in subsequent sections.

Cocaine and Its Markets

If opium and heroin defined the drug trade of the nineteenth century and much of the first half of the twentieth, cocaine defined the drug trade of the 1970s and 1980s and reshaped organized crime in the Americas in ways whose consequences are still being felt. Cocaine's rise to prominence as the defining drug of the late twentieth century was the product of demand-side changes in wealthy consuming societies, the development of efficient supply chains rooted in South American coca cultivation, and the emergence of Colombian trafficking organizations that became, for a period, among the most powerful criminal enterprises in history.

Coca Cultivation and the Andean Economy

The coca plant, Erythroxylum coca, is native to the eastern slopes of the Andes in South America and has been cultivated there for thousands of years. In its traditional form, coca leaves are chewed or brewed into tea and produce mild stimulant effects far less powerful than processed cocaine. Indigenous Andean communities used coca in religious ceremonies, as a remedy for altitude sickness, and as a daily stimulant to sustain physical labor at high altitudes. The Spanish colonial authorities initially attempted to suppress coca use as a pagan practice before recognizing its utility in sustaining the productivity of indigenous mine and agricultural laborers and permitting, indeed encouraging, its cultivation and use.

The isolation of cocaine hydrochloride from coca leaves in the 1850s and 1860s transformed the international significance of the plant. Cocaine was a powerful central nervous system stimulant, and it was initially marketed enthusiastically in Europe and North America for medicinal and recreational purposes. Legal restriction beginning in the 1910s did not eliminate demand but drove it underground. By mid-century, cocaine was a relatively minor illegal market, limited primarily to entertainment and bohemian milieus. The explosion of the 1970s and 1980s was driven by cultural change in the United States: the association of cocaine with affluence, youth culture, and the celebrity world made it fashionable among exactly the demographic groups with the resources to pay premium prices for an expensive drug. Demand grew rapidly, and the economics of the illegal market rewarded whoever could build the supply chains to meet it.

The Rise of Colombian Trafficking Organizations

Colombia was not the original source of the cocaine that entered American markets in the early 1970s. Much of the early supply came through networks of Cuban exiles and South American migrants with connections to cocaine-producing regions. What Colombian trafficking entrepreneurs recognized was the enormous opportunity available to whoever controlled the logistics chain between South American coca, where they had existing connections, and the burgeoning American market. Figures like Carlos Lehder Rivas and eventually the founders of the Medellín and Cali cartels built the transportation infrastructure, the distribution networks, and the systems of corruption and violence that would allow Colombian organizations to dominate the cocaine trade for the next two decades.

The organizational innovations of the Colombian trafficking world are examined in more detail in Chapter 22. For the purposes of this chapter, it is sufficient to note that the cocaine boom of the 1980s generated revenues so large that they fundamentally distorted the Colombian economy and political system. Estimates of Colombian cocaine revenues varied widely, but credible estimates suggested that cocaine trafficking generated billions of dollars per year in export earnings that rivaled or exceeded legitimate exports for significant periods. This concentration of illegal wealth gave trafficking organizations enormous political leverage, which they exercised through a mixture of bribery and extreme violence directed at politicians, judges, police officers, and journalists who opposed them.

Crack Cocaine and the American Epidemic

The cocaine epidemic of the 1980s had distinct phases with very different social profiles. Powder cocaine, expensive and associated with affluent users, was the dominant form through the early part of the decade. The emergence of crack cocaine, a form of the drug that could be smoked and was sold in small quantities at much lower unit prices, transformed the market from the mid-1980s onward. Crack was cheap enough to reach consumers in poor urban communities who could not afford powder cocaine, and its method of ingestion produced a faster and more intense high, with correspondingly higher addiction potential.

The crack epidemic devastated urban communities across the United States, producing sharply rising rates of addiction, associated health problems, violence linked to competition for distribution territory, and the social disruption of mass addiction among parents and family members. The policy response was to treat crack cocaine as a uniquely dangerous substance warranting especially severe criminal penalties. The 1986 Anti-Drug Abuse Act established a sentencing disparity under which possession of five grams of crack cocaine triggered the same mandatory minimum sentence as possession of five hundred grams of powder cocaine, a hundred-to-one disparity that was not reduced to eighteen to one until the Fair Sentencing Act of 2010. Because crack users were disproportionately Black and powder cocaine users disproportionately white, this disparity produced dramatically racially unequal criminal justice outcomes that became one of the most prominent examples of racial bias in American drug policy. The two forms of cocaine are pharmacologically equivalent, and the rationale for differential sentencing was never established on pharmacological grounds.

The Collapse of the Colombian Cartels and the Balloon Effect

The Medellín and Cali cartels, as Chapter 22 discusses in detail, were eventually dismantled through a combination of Colombian state action, American law enforcement pressure, and internal fragmentation. Pablo Escobar was killed in 1993. The Cali cartel leadership was arrested in 1995. But the destruction of the major Colombian organizations did not reduce cocaine supply to American markets. It illustrates what drug policy scholars call the "balloon effect": squeeze in one place and the problem expands elsewhere. Colombian trafficking fragmented into dozens of smaller organizations, while Mexican cartels, which had been serving as hired transporters for the Colombians, seized the opportunity to take direct control of the US distribution market. The supply chain reconfigured itself around new organizational centers without any meaningful reduction in overall supply.

Colombia, Peru, and Bolivia continue to dominate global coca cultivation and cocaine production into the twenty-first century. Colombia has remained the largest single producer despite decades of American-funded eradication and interdiction programs. The Andean cocaine economy continues to generate billions of dollars in revenues that flow through complex supply chains toward consuming markets in North America, Western Europe, and, increasingly, new markets in Australia, East Asia, and Brazil.

Heroin: From Medicine to Crisis

Heroin's modern history spans more than a century of legal use, criminalization, epidemic spread, partial control, and renewed crisis. No other substance has demonstrated more clearly the relationship between pharmaceutical innovation, commercial marketing, legal prohibition, and the creation of addicted populations that serve as captive markets for illegal trafficking.

Bayer Pharmaceuticals introduced heroin, the brand name for diacetylmorphine, in 1898 as a supposedly non-addictive substitute for morphine and as a cough medicine for children. The name derived from the German heroisch, meaning heroic, a reference to the feelings of power and euphoria that users reported. The company aggressively marketed heroin through medical journals and physician samples, and it was widely used for both medical treatment and recreational purposes throughout the early twentieth century. The recognition that heroin was more addictive than morphine, not less, came gradually and was resisted by commercial interests. By the time serious legal restriction began in the 1920s, substantial populations of dependent users existed in both Europe and North America.

The American Heroin Epidemic of the 1960s and 1970s

Heroin re-emerged as a major American public health crisis in the 1960s, concentrated in urban African American communities. The social disruption of the urban crisis, the collapse of manufacturing employment, and the deterioration of inner-city neighborhoods created conditions in which heroin use spread rapidly. This epidemic was associated in the public mind, not always accurately, with crime, and it shaped both drug enforcement priorities and public attitudes toward drug users. Vietnam veterans also returned home with heroin addiction contracted in Southeast Asia, where the drug was cheap and plentiful, introducing dependent users into communities across the country and across racial lines.

The Nixon administration's declaration of a War on Drugs in 1971 was partly a response to the heroin crisis and partly, as Nixon aide John Ehrlichman later admitted in a 1994 interview, a political strategy to associate heroin with Black urban communities and cannabis with anti-war protesters, two groups Nixon wished to politically marginalize. Ehrlichman's candid admission decades later confirmed what critics had long argued: that drug policy in the United States was shaped not only by public health considerations but by racial politics and the use of criminalization as an instrument of social control.

The Opioid Crisis of the Late Twentieth and Early Twenty-First Centuries

The most consequential chapter in the recent history of opioid use in the United States began not with illegal trafficking but with the legal pharmaceutical industry. Beginning in the mid-1990s, pharmaceutical companies, most notoriously Purdue Pharma, manufacturer of OxyContin, marketed powerful prescription opioids to physicians with misleading assurances about their addiction potential and therapeutic benefits. Physicians, many of them responding in good faith to a legitimate medical movement emphasizing better pain management, prescribed these drugs in enormous quantities. Patients who became physically dependent on prescription opioids often found that when their prescriptions were cut off, heroin available on the street was cheaper and more accessible than the drugs to which they were addicted. Many transitioned from prescription opioids to heroin, and subsequently to illicitly manufactured fentanyl, which entered American drug markets in large quantities from the mid-2010s onward.

The synthetic opioid crisis, driven primarily by fentanyl and its analogues, produced a public health catastrophe of a scale not seen in American history. Fentanyl is approximately fifty to one hundred times more potent than morphine, and its high potency means that the margin between an effective dose and a lethal one is extremely narrow. Mixed into supplies of heroin, cocaine, methamphetamine, and counterfeit prescription pills by traffickers who used it to enhance or adulterate their products, fentanyl produced a wave of accidental overdose deaths that killed tens of thousands of Americans per year. Drug overdose deaths in the United States, the majority involving synthetic opioids, exceeded 100,000 in 2021, surpassing all other causes of accidental death and representing one of the most severe public health emergencies in American history.

The opioid crisis differed from earlier drug epidemics in its geographic and demographic profile. Its initial phase, driven by prescription opioids, was concentrated in rural and suburban white communities, particularly in the Appalachian region, where OxyContin and similar drugs had been aggressively marketed and where economic decline had created conditions of hopelessness and social dissolution that correlate with elevated drug use. This demographic profile initially generated a more sympathetic public and political response than the crack cocaine epidemic had received, raising sharp questions about whether the race of affected communities shaped the policy response.

Methamphetamine Markets

Methamphetamine represents a fundamentally different category of illegal drug from the plant-based narcotics that have dominated much of this chapter. As a synthetic stimulant, it does not require specific agricultural conditions for its production, it is not dependent on cultivation in particular geographic regions, and it can be manufactured from widely available chemical precursors in clandestine laboratories that can be established almost anywhere. This geographic flexibility gives the methamphetamine market a very different structure from the opium and cocaine markets and poses different challenges for law enforcement.

Amphetamines were first synthesized in 1887 and methamphetamine in 1919. They were used extensively during the Second World War by military forces on multiple sides, issued to soldiers to sustain combat performance, reduce fatigue, and elevate aggression. Japan, whose military used methamphetamine extensively during the war, experienced a severe epidemic of postwar amphetamine abuse as surplus military supplies entered civilian markets. The immediate postwar period in Japan produced what was effectively the first major methamphetamine epidemic, handled through a combination of criminalization and public health measures. Japanese criminal organizations, including the Yakuza discussed in Chapter 17, became involved in the postwar amphetamine market and retained significant roles in subsequent decades.

In the United States, methamphetamine abuse spread through multiple communities over the second half of the twentieth century. Biker gangs, particularly outlaw motorcycle clubs such as the Hells Angels, were early producers and distributors of methamphetamine, especially on the West Coast. By the 1990s, methamphetamine use had expanded significantly in rural and suburban communities across the American West and Midwest. Small "mom and pop" laboratories using relatively accessible precursor chemicals produced low-quality product for local distribution. The Combat Methamphetamine Epidemic Act of 2005, which restricted sales of pseudoephedrine and ephedrine, the primary precursor chemicals for domestic methamphetamine production, effectively reduced domestic small-scale production but did not reduce overall supply. Instead, Mexican trafficking organizations, particularly the Sinaloa Cartel, moved into large-scale industrial production of high-purity methamphetamine in Mexico and began importing it into the United States in quantities that replaced and exceeded the domestic production that had been disrupted. The pattern, once again, illustrated the balloon effect: suppression of one segment of supply simply redirects the market to new suppliers.

Methamphetamine has also become a major commodity in the Asian drug trade, where it circulates primarily in the form of tablets known as yaba (meaning "crazy drug" in Thai). Production is concentrated in the Shan State of Myanmar, controlled by ethnic armed organizations that have diversified from opium into synthetic drugs as production became more profitable and less vulnerable to crop eradication. The Golden Triangle, long known for opium, has become a major synthetic drug production zone, with yaba tablets distributed across Southeast and East Asia. Chinese consumption of synthetic drugs has grown substantially, making China an increasingly important destination market and a significant source of chemical precursors for methamphetamine production elsewhere.

Supply Chains and the Logistics of Trafficking

One of the most striking features of the modern global drug trade, viewed as an economic system, is the sophistication of its logistics. Moving hundreds of tons of illegal narcotics from cultivation zones in Afghanistan, Colombia, or Myanmar to street markets in Chicago, London, or Sydney requires transportation systems, communication networks, financial infrastructure, and corruption at multiple levels that rival the complexity of legitimate global supply chains. Understanding how these logistics work, and why they have proved so difficult to disrupt, is central to understanding the durability of the drug trade.

Methods of Transportation

Drug trafficking organizations have historically used every available method of transportation and have proved extraordinarily inventive in adapting to law enforcement pressure. Maritime shipping containers, which carry the vast majority of global trade and are impossible to search comprehensively, have been used to move enormous drug shipments concealed within legitimate cargoes. Commercial aviation has served as a transportation channel for smaller shipments, with couriers, sometimes called "mules," carrying drugs on their persons, in their luggage, or even within their bodies in swallowed packets. Purpose-built semi-submersible vessels, sometimes called narco-submarines, have been used by Colombian trafficking organizations to move cocaine across the Pacific and Caribbean beneath the radar of coast guard surveillance. Tunnels beneath the US-Mexico border, some of them elaborate engineered structures with electric lighting, rail systems, and ventilation, have moved many tons of drugs across the border. Drones have more recently been used for small-scale cross-border deliveries. Commercial mail and express parcel services have carried drug shipments, including fentanyl sourced from Chinese chemical laboratories, in quantities too small and too numerous for comprehensive screening.

Each innovation in trafficking method has prompted a law enforcement response, and each law enforcement response has prompted further innovation. The pattern is one of adversarial adaptation in which the resources and creativity of trafficking organizations, backed by enormous profit margins, have consistently matched or exceeded the capacity of enforcement systems. The economic asymmetry is critical: a trafficking organization earns enormous revenues from successful shipments and writes off seized shipments as a cost of doing business, whereas law enforcement must allocate limited resources across an enormous number of potential interdiction points.

The Role of Corruption

No discussion of drug supply chains is complete without addressing the central role of corruption. Transportation of drugs across international borders, through ports and airports and checkpoints, cannot occur at commercial scale without the cooperation, or at least the deliberate inattention, of customs officials, border guards, police, and other state agents. Trafficking organizations invest heavily in corruption as a business expense, bribing officials along their supply chains to ensure that shipments are not inspected, that warnings are provided before raids, that arrested traffickers are released, and that prosecution is compromised. In countries where official salaries are low and state institutions are weak, the sums offered by trafficking organizations are simply irresistible to many officials.

The corruption extends far beyond border officials. Police investigators who accept bribes to discard evidence. Prosecutors who accept payments to pursue other cases. Judges whose verdicts are purchased. Politicians who receive campaign contributions, laundered through legitimate businesses, in exchange for legislative protection or policy influence. Military officers who provide protection for convoys. Port managers who arrange for containers to pass without inspection. The web of corruption surrounding a major trafficking organization can extend through every level of the institutions that are supposed to control it.

Financial Infrastructure

The drug trade generates cash, vast quantities of it, at the retail distribution level. Moving that cash through financial systems without triggering scrutiny is one of the central logistical challenges of drug trafficking and the subject of Chapter 28 on money laundering. Briefly, trafficking organizations use a variety of mechanisms to convert drug cash into apparently legitimate financial assets: cash-intensive businesses such as restaurants, car washes, money exchange houses, and construction companies; currency smuggling across borders; trade-based money laundering that manipulates the invoicing of legitimate international trade; real estate purchases; and increasingly the use of cryptocurrency and other digital value transfer systems. The financial infrastructure of the drug trade is deeply embedded in legitimate economies and financial institutions in ways that make it extraordinarily difficult to fully trace or disrupt.

Demand, Consumption, and Society

The supply side of the global drug trade, however vast and complex, is ultimately driven by demand. Without persistent, price-inelastic consumption of illegal drugs in wealthy countries, the elaborate and violent supply chains that move narcotics across the world would have no reason to exist. Understanding who uses drugs, why they do so, and how demand shapes and is shaped by social conditions is essential to a complete picture of the drug trade as a historical phenomenon.

Who Uses Drugs and Why

Drug use is not evenly distributed across social populations. Numerous factors correlate with elevated rates of problematic drug use, including poverty and economic insecurity, exposure to trauma and adverse childhood experiences, untreated mental health conditions, social isolation, and residence in communities with high concentrations of these risk factors. This does not mean that drug use is confined to the poor or the socially marginalized. Cocaine use, particularly in its powder form, has historically been concentrated among affluent users. Cannabis use has been widespread across income groups. Prescription opioid addiction, in its early phases, disproportionately affected rural communities across the economic spectrum rather than the urban poor.

The social meaning and function of drug use also varies considerably. For many users, drugs represent recreational pleasure or social bonding, consumed occasionally without developing physical or psychological dependence. For others, particularly those experiencing untreated trauma, mental illness, chronic pain, or profound hopelessness, drugs provide a form of self-medication or escape from conditions of suffering. Understanding the relationship between social conditions and drug use is crucial for understanding why demand persists despite prohibition and why enforcement-focused approaches that do not address underlying social conditions have consistently proved insufficient.

Race, Class, and Drug Policy

One of the most persistent and troubling features of drug policy in the United States and in many other countries is the degree to which enforcement has fallen disproportionately on racial minorities and the poor, even when drug use rates across racial groups are roughly comparable. Studies have consistently found that Black Americans are arrested for drug offenses at several times the rate of white Americans despite similar rates of drug use. Sentencing disparities, prosecutorial discretion, policing patterns concentrated in poor communities of color, and implicit racial bias in the criminal justice system collectively produce an enforcement pattern that treats drug use as a serious crime when it occurs in Black and Latino communities while treating it with much greater leniency when it occurs among white users.

These patterns did not emerge by accident. Harry Anslinger, the first commissioner of the Federal Bureau of Narcotics and the most influential figure in shaping early American drug prohibition, explicitly connected drug use to racial minorities in his public advocacy and in his communications with the press. Heroin was associated with Black jazz musicians. Marijuana was linked to Mexican immigrants and portrayed as producing violent, uncontrollable behavior. Cocaine, in the early twentieth century, generated extraordinary racial fear, with claims that cocaine-using Black men were becoming impervious to bullets and a threat to white women. These racial narratives shaped enforcement patterns that fell most heavily on communities of color and that have persisted in various forms through to the present day.

The War on Drugs: History, Policy, and Consequences

No chapter on the global drug trade would be complete without a serious examination of the "War on Drugs," the framework of escalating criminalization and enforcement that has dominated international drug policy since the 1970s and whose consequences, both intended and unintended, have shaped the world described throughout this chapter. The War on Drugs is not simply a historical policy but a still-ongoing framework whose fundamental premises are increasingly contested in light of decades of evidence about its effects.

Nixon and the Declaration of War

In June 1971, President Richard Nixon declared drug abuse "public enemy number one" and called for a nationwide effort to combat narcotics, which he characterized as a national emergency. The declaration formalized a shift in American drug policy from a primarily medical and regulatory framework to a law enforcement framework. Nixon created the Drug Enforcement Administration in 1973, consolidating federal drug enforcement in a single agency with broad investigative powers. The Controlled Substances Act of 1970 established a classification system for drugs according to their abuse potential and medical utility, with Schedule I, the most restrictive category, reserved for substances deemed to have no accepted medical use and high abuse potential. Cannabis was placed in Schedule I alongside heroin, a classification that remains controversial on scientific grounds.

The international dimension of American drug policy expanded dramatically under Nixon and his successors. The United States applied diplomatic, economic, and military pressure to drug-producing countries to comply with its drug control agenda, conditioning foreign aid and trade relations on cooperation with American drug enforcement priorities. This pressure took various forms: funding for eradication programs that paid or pressured producing countries to destroy coca and poppy crops, direct DEA operations in foreign countries, training and equipping of foreign military and police units for counter-narcotics operations, and in some cases direct American military involvement as in the post-9/11 counter-narcotics mission in Afghanistan.

Reagan, Crack, and Mass Incarceration

The Reagan administration dramatically escalated the War on Drugs in the 1980s, in response to the crack cocaine epidemic but also as part of a broader conservative political project of law-and-order governance. Federal drug enforcement budgets increased dramatically. Mandatory minimum sentencing laws, including the racially disparate crack-powder cocaine sentencing disparity, removed judicial discretion and mandated long prison sentences for drug offenses. The result was a dramatic expansion of the American prison population. The number of Americans incarcerated for drug offenses rose from approximately fifty thousand in 1980 to more than four hundred thousand by the late 1990s, making drug offenses one of the largest drivers of mass incarceration. The United States, which already had the highest incarceration rate in the world, saw its prison population expand to more than two million by the early 2000s, a per capita incarceration rate dramatically higher than any other democratic country.

The social and racial consequences of this expansion were severe and highly concentrated. Black Americans were incarcerated for drug offenses at rates far exceeding their representation in the drug-using population. Entire communities lost large proportions of their working-age male population to incarceration, creating devastating effects on family structure, child development, economic life, and political participation. Mass incarceration for drug offenses became one of the most powerful mechanisms of racial inequality in late twentieth-century America, intersecting with the racial disparities in drug enforcement that had characterized American policy since Anslinger's era.

International Consequences: Plan Colombia and Beyond

The United States extended the War on Drugs into producing countries through a series of major policy initiatives. Plan Colombia, launched in 2000 with several billion dollars in American funding, combined counter-narcotics operations with counter-insurgency and military capacity-building to reduce cocaine production and disrupt Colombian trafficking organizations. The program included aerial eradication of coca crops using glyphosate, support for Colombian military and police operations against trafficking organizations, and extensive assistance to the Colombian state's broader effort to reassert territorial control.

The results were mixed and illustrated the structural challenges of supply-side interdiction. Colombian government capacity improved significantly, and the major cartels were dismantled. However, coca cultivation migrated to Peru and Bolivia, and trafficking functions were absorbed by smaller Colombian organizations and by Mexican cartels. Overall cocaine supply to American markets did not decrease significantly. The aerial eradication program generated significant controversy for its effects on the health of rural communities, on legitimate crops, and on the biodiversity of Andean ecosystems.

The Global Drug Economy Today

The global drug trade of the early twenty-first century is larger, more complex, and in some respects more dangerous than at any previous point in history. A number of developments in recent decades have transformed the landscape in ways that present new challenges for law enforcement, public health systems, and the communities most affected by the trade.

The Fentanyl Revolution

The most consequential development in the American drug market in the past decade has been the displacement of heroin by illicitly manufactured fentanyl and related synthetic opioids. Fentanyl, legally manufactured for medical use in the treatment of severe pain, began appearing in illicit drug supplies around 2013 and rapidly became the dominant substance driving opioid overdose deaths. Its extreme potency, combined with the difficulty of precisely dosing an active compound so powerful that a few micrograms separates a high from a fatal dose, made fentanyl-adulterated drug supplies extraordinarily deadly.

The supply chain for illicit fentanyl has evolved rapidly. Initial supplies were produced by Chinese chemical laboratories and shipped directly to American consumers through the postal system. After US and Chinese regulatory actions reduced this direct supply, production shifted largely to Mexican cartels, particularly the Sinaloa and Jalisco New Generation Cartels, which now manufacture fentanyl and fentanyl-laced pills in enormous quantities using chemical precursors imported from China and other sources. The cartels' existing distribution networks, built over decades for cocaine, heroin, and methamphetamine, provide ready-made channels for fentanyl distribution throughout the United States. The synthetic drug revolution has made the supply chain less dependent on agricultural production in specific geographic regions and therefore less vulnerable to the eradication and interdiction strategies that have been the primary tools of supply-side drug enforcement for decades.

The Dark Web and Digital Drug Markets

The internet, and particularly the encrypted dark web markets that emerged from the early 2010s onward, has created a new distribution channel for drug commerce that bypasses many of the geographic constraints of traditional trafficking. Beginning with the Silk Road marketplace, shut down by the FBI in 2013, a succession of online drug markets have allowed buyers in consuming countries to purchase drugs directly from producers or wholesalers and receive them by mail, eliminating the need for local distribution networks. Dark web drug markets have been repeatedly disrupted by law enforcement, but new platforms consistently replace shut-down predecessors, illustrating once again the resilience of criminal markets in the face of enforcement pressure. This dimension of the drug trade is examined more fully in Chapter 30.

Cannabis Liberalization and Its Implications

The most significant legal development in drug policy of recent decades has been the accelerating legalization of cannabis for recreational use in a growing number of jurisdictions. As of the mid-2020s, cannabis is legally sold for recreational use in over twenty American states, Canada, Uruguay, and several European countries, with legal or decriminalized status extending across a much larger number of jurisdictions globally. This shift represents the most significant departure from the international prohibition regime established in 1961 and has proceeded despite the nominal requirement of the UN drug conventions that signatory states maintain prohibition.

The legalization of cannabis in major jurisdictions has significant implications for organized crime. Cannabis was historically an important revenue source for criminal organizations in North America and elsewhere. Legal cannabis markets have displaced a significant portion of the illegal market in jurisdictions where it has been legalized, reducing organized crime revenues from this commodity. However, illegal cannabis markets have not been entirely eliminated, partly because legal markets are still more expensive due to taxation and regulation, partly because legal markets do not serve consumers in all areas, and partly because the transition from illegal to legal supply chains takes time and involves ongoing competition. The experience of cannabis legalization also provides evidence, increasingly drawn on by drug policy reformers, that legal regulation of a previously prohibited substance can reduce illegal market activity without producing the catastrophic increases in use that prohibition advocates predicted.

Research or Library Extension